NCT02526485View on ClinicalTrials.gov

Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

September 5, 2018

Study Completion Date

September 5, 2018

Conditions
Heparin-induced Thrombocytopenia
Interventions
PROCEDURE

Blood Draw

A one time blood draw of 150 milliliters will be performed using a vein in the participants arm. Existing venous access will be used for the blood draw in preference of new venipuncture.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Vanderbilt University Medical Center

OTHER

NCT02526485 - Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2 | Biotech Hunter | Biotech Hunter